TickerSutra

NSE: JKTYRE · BSE: 530007 · ISIN INE573A01042

JK Tyre & Industries Limited stock analysis

JK Tyre & Industries Limited ranks #2557 in the TickerSutra evidence-ranked universe with a score of 46/100 and 95% data confidence. The latest captured fundamentals show ROCE of 15.5%, quarterly sales growth of 2.0% and quarterly profit growth of -76.6%.
Complete evidence gate watch governance reviewUpdated 29 Sept 2026
TICKERSUTRA SCORE46/100

Avoid / exit review

#2557 of 5,430 ranked equities
Market capitalisation₹10,506.7cr
ROCE15.5%
Quarterly sales growth2.0%
Quarterly profit growth-76.6%
P/E ratio14.6×
Promoter pledge0.0%

INVESTMENT EVIDENCE

What supports—and challenges—the thesis

Evidence in favour

  • CWIP indicates an active capacity pipeline
  • No promoter shares are reported as pledged

Risks and constraints

  • Debt/equity is above 0.5×

Still unresolved: Related-party exposure · Broad media sentiment

FINANCIAL TRAJECTORY

Recent operating history

PeriodRevenueOperating profitNet profitOperating margin
2022₹11,983cr₹1,073cr₹201cr9.0%
2023₹14,645cr₹1,298cr₹263cr9.0%
2024₹15,002cr₹2,091cr₹806cr14.0%
2025₹14,693cr₹1,599cr₹509cr11.0%
2026₹16,327cr₹2,031cr₹776cr12.0%
TTM₹16,404cr₹1,887cr₹657cr12.0%
Debt / equity0.81×
CFO / EBITDA0.71×
Operating margin12.0%
Free cash flow₹38cr
Sales CAGR · 3Y3.7%
Profit CAGR · 3Y43.4%

EXCHANGE EVENT TRIGGERS

Latest corporate disclosures

0 positive catalysts0 negative catalysts3 routine filings

MANAGEMENT COMMENTARY

Signals from filed documents

Operating leverageHigh severity · 2 mentions
Positive catalyst

20% v/s Q4FY26, which impacted our gross and operating margins. We are offsetting the same by taking selling price increases in a staggered manner, enriching our product mix, higher share of value added products, operating leverages, and taking efficiency improvement measures. We are hoping that the recent moderation in commodity and crude oil prices are expected to lower input costs and improve profitability margins

Raw material inflationHigh severity · 2 mentions
Risk easing

3) EBITDA margins (Consolidated) in Q1 were recorded at 6.8% v/s 10.9% in Q1FY26. 4) Average raw material costs in Q1 were up by ~20% on sequential basis. 5) Cash profits for Q1FY27 stood at Rs.169 crore v/s Rs.309 crore in corresponding quarter.

Margin expansionHigh severity · 1 mention
Positive catalyst

But otherwise, things are normalizing. And once these costs are stabilized, we will be able to see a good margin improvement from at least 2nd half of this financial year . So, we are expecting all the 3 quarters now onwards should be on a progressive basis, improving in terms of margins.

Pricing commentaryModerate severity · 7 mentions
Constructive

20% v/s Q4FY26, which impacted our gross and operating margins. We are offsetting the same by taking selling price increases in a staggered manner, enriching our product mix, higher share of value added products, operating leverages, and taking efficiency improvement measures. We are hoping that the recent moderation in commodity and crude oil prices are expected to lower input costs and improve profitability margins

Capacity expansion plansModerate severity · 2 mentions
Positive catalyst

And what kind of revenue growth are we expecting this year on an overall basis? Because I think there's some new capacity, which has come as well, right? Sanjeev Aggarwal: Yes, this was already there and some ramp-up is also happening in PCR.

Regulatory updatesLow severity · 15 mentions
Watch

Not Applicable (classified as an Opportunity). Positive 7 Business Ethics and Conduct Risk Operating across multiple geographies with a large supplier and dealer network, the Company is exposed to risks of bribery, corruption, anti-competitive conduct, fraud and regulatory non- compliance. Lapses in ethical conduct can result in penalties, litigation, loss of OEM and customer trust and reputational damage.

Regulatory approvalLow severity · 1 mention
Watch

Whether your entity’s policy/ policies cover each principle and its core elements of the NGRBCs. Has the policy been approved by the Board? Web link of the policies, if available Y Y Y Y Y Y Y Y Y 2.

Export market updatesLow severity · 1 mention
Watch

These present downside risk to margins, while disciplined cost management and growth in premium, export and EV segments create upside opportunity. The Company manages this through raw-material sourcing strategies, cost- optimisation and operational-efficiency programmes, product-mix enrichment and diversification across OEM, replacement and export markets. Both 10 Pollution Opportunity and Risk Manufacturing generate

Institutional interestLow severity · 1 mention
Watch

MSME for other Raw material categories No Supplier Engagement Events, Periodic Visits, etc Yearly Identification of Opportunities for Improvement Shareholders No Email, Meetings, Newspaper, Company website, Stock Exchanges, other Statutory Authority Regularly through Company’s website and website of Stock Exchanges, through Annual General Meetings/ Extraordinary General Meetings Disseminating and sharing of informati

HOW TO READ THIS PAGE

Evidence, freshness and limitations

What does the TickerSutra score mean?

The score ranks captured evidence across financial quality, growth, moat and margins, regulatory catalysts, governance, institutional trend and valuation comfort. It is a research-prioritization tool—not a buy recommendation or price target.

Which sources support this page?

Financial history, ownership and pledge data, NSE and BSE filings, annual reports and available earnings-call transcripts are combined here. Use the source trail and original exchange document before relying on a decision-critical fact.

Why can an item be unresolved?

Unresolved means the current captured source window did not provide enough evidence for that check. It does not establish that a risk or relationship is absent.

Maintained by TickerSutra Research · Snapshot updated 29 Sept 2026 · Read the methodology · Read the disclaimer

DIRECTOR & BUSINESS NETWORK

Loading corporate intelligence

Loading universe coverage and exchange-backed evidence…